New data for TAGRISSO® (osimertinib) has been published, attached is a resource you may find beneficial.

By Kathy Musson
On November 6th, 2025

To learn more about the latest data from TAGRISSO, visit the website here.

Please see full Prescribing Information, including Patient Information for TAGRISSO.

A black text on a white background AI-generated content may be incorrect.
A close-up of a logo AI-generated content may be incorrect.

TAGRISSO is a registered trademark of the AstraZeneca group of companies.

©2025 AstraZeneca.    All rights reserved.    US-105694   Last Updated 10/25

No comments have been posted yet.